Li, Changyou <br/><br/>
Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation.  [electronic resource] 

 -  Cancer letters  Jan 2012 
 - 102-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2011.09.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Autophagy--drug effects<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Line, Tumor<br/>Enzyme Activation<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>JNK Mitogen-Activated Protein Kinases--physiology<br/>Phosphorylation<br/>Protease Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Pyrazines--pharmacology<br/>Squamous Cell Carcinoma of Head and Neck